Prostaglandin analogues preserved with benzalkonium chloride (BAK) can cause more extensive loss of goblet cells and a breakdown of cell-cell adhesions, which could increase the risk of ocular surface disease, according to findings from a pair of studies conducted in rabbits.
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.